---
$id: https://graph.org.ai/products/commodity/51202902
$type: Product
source: UNSPSC
code: "51202902"
title: "Defibrotide"
class: "51202900"
classTitle: "Immunosupressant nucleic acids, nucleotides, and nucleosides"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Defibrotide

**UNSPSC Code**: 51202902
**Class**: [Immunosupressant nucleic acids, nucleotides, and nucleosides](Immunosupressant nucleic acids, nucleotides, and nucleosides.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppessant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 438HCF2X0M, chemically known as sodium salt of a mixture of single-stranded oligodeoxyribonucleotides derived from bovine lung dna. European Medicines Agency schedules defibrotide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01572MIG. Most nations, for tariff and trade purposes, schedule Defibrotide under HS 30012090 and SITC 54162. SMILES:. Defibrotide bears US NLM identifiers UMLS ID C0057257 and NCI Concept Code C1064.

